Reconciliations of Non-GAAP Financial Measures
June 30, 2024
(Unaudited)
SABRA HEALTH CARE REIT, INC.
2024 OUTLOOK
The table below sets forth our 2024 guidance (per diluted common share):
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | Low | | High |
| Net income | | | | | $ | 0.48 | | | $ | 0.51 | |
| Add: | | | | | | | |
| Depreciation and amortization of real estate assets | | | | | 0.72 | | | 0.72 | |
| Depreciation and amortization of real estate assets related to unconsolidated joint ventures | | 0.03 | | | 0.03 | |
| | | | | | | |
| Net loss on sales of real estate | | | | | 0.10 | | | 0.10 | |
| FFO | | | | | $ | 1.33 | | | $ | 1.36 | |
| | | | | | | |
| Normalizing items | | | | | 0.03 | | | 0.03 | |
| Normalized FFO attributable to common stockholders | | | | | $ | 1.36 | | | $ | 1.39 | |
| | | | | | | |
| FFO attributable to common stockholders | | | | | $ | 1.33 | | | $ | 1.36 | |
| Stock-based compensation expense | | | | | 0.04 | | | 0.04 | |
| Non-cash rental and related revenues | | | | | (0.03) | | | (0.03) | |
| | | | | | | |
| Non-cash interest expense | | | | | 0.04 | | | 0.04 | |
| | | | | | | |
| | | | | | | |
| Other adjustments | | | | | 0.01 | | | 0.01 | |
| AFFO | | | | | $ | 1.39 | | | $ | 1.42 | |
| | | | | | | |
| Normalizing items | | | | | 0.02 | | | 0.02 | |
| Normalized AFFO attributable to common stockholders | | | | | $ | 1.41 | | | $ | 1.44 | |
| | | | | | | |
Earnings guidance above:
•assumes year-over-year same store Cash NOI growth in the mid-to-high teens for the Senior Housing - Managed portfolio;
•incorporates all announced investment and disposition activity, as well as announced activity under the at-the-market equity offering program; and
•does not assume additional investment, disposition or capital transactions beyond those already disclosed.
The foregoing guidance ranges reflect management's view of current and future market conditions. There can be no assurance that the Company's actual results will not differ materially from the estimates set forth above. Except as otherwise required by law, the Company assumes no, and hereby disclaims any, obligation to update any of the foregoing guidance ranges as a result of new information or new or future developments.
See reporting definitions. 2
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
FFO, Normalized FFO, AFFO and Normalized AFFO
(dollars in thousands, except per share data)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
| | 2024 | | 2023 | | 2024 | | 2023 |
| Net income | $ | 23,975 | | | $ | 21,188 | | | $ | 50,229 | | | $ | 11,701 | |
| Add: | | | | | | | |
| Depreciation and amortization of real estate assets | 41,681 | | | 44,142 | | | 84,595 | | | 96,969 | |
| | | | | | | |
| Depreciation, amortization and impairment of real estate assets related to unconsolidated joint ventures | 2,208 | | | 2,202 | | | 4,437 | | | 4,250 | |
| Net (gain) loss on sales of real estate | (1,776) | | | 7,833 | | | (1,776) | | | 29,348 | |
| | | | | | | |
| Impairment of real estate | 15,335 | | | — | | | 18,472 | | | 7,064 | |
| | | | | | | |
| FFO | $ | 81,423 | | | $ | 75,365 | | | $ | 155,957 | | | $ | 149,332 | |
| | | | | | | |
| Write-offs of cash and straight-line rental income receivable and lease intangibles | — | | | — | | | 2,921 | | | 540 | |
| | | | | | | |
| Loss on extinguishment of debt | — | | | — | | | — | | | 1,541 | |
| (Recovery of) provision for loan losses | (161) | | | 429 | | | (298) | | | 221 | |
| | | | | | | |
| | | | | | | |
Other normalizing items (1) | 1,274 | | | 1,301 | | | 2,395 | | | 2,069 | |
| Normalized FFO | $ | 82,536 | | | $ | 77,095 | | | $ | 160,975 | | | $ | 153,703 | |
| FFO | $ | 81,423 | | | $ | 75,365 | | | $ | 155,957 | | | $ | 149,332 | |
| Stock-based compensation expense | 1,341 | | | 1,004 | | | 3,862 | | | 3,233 | |
| Non-cash rental and related revenues | (2,387) | | | (3,071) | | | (1,796) | | | (5,469) | |
| Non-cash interest income | 5 | | | 4 | | | 12 | | | (388) | |
| Non-cash interest expense | 3,068 | | | 3,077 | | | 6,139 | | | 6,091 | |
| Non-cash portion of loss on extinguishment of debt | — | | | — | | | — | | | 1,541 | |
| (Recovery of) provision for loan losses | (161) | | | 429 | | | (298) | | | 221 | |
| | | | | | | |
| | | | | | | |
| Other adjustments related to unconsolidated joint ventures | 135 | | | 169 | | | 288 | | | 238 | |
| Other adjustments | 429 | | | 291 | | | 839 | | | 693 | |
| AFFO | $ | 83,853 | | | $ | 77,268 | | | $ | 165,003 | | | $ | 155,492 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Other normalizing items (1) | 1,126 | | | 1,286 | | | 2,232 | | | 2,038 | |
| Normalized AFFO | $ | 84,979 | | | $ | 78,554 | | | $ | 167,235 | | | $ | 157,530 | |
| Amounts per diluted common share: | | | | | | | |
| Net income | $ | 0.10 | | | $ | 0.09 | | | $ | 0.22 | | | $ | 0.05 | |
| FFO | $ | 0.35 | | | $ | 0.32 | | | $ | 0.67 | | | $ | 0.64 | |
| Normalized FFO | $ | 0.35 | | | $ | 0.33 | | | $ | 0.69 | | | $ | 0.66 | |
| AFFO | $ | 0.36 | | | $ | 0.33 | | | $ | 0.70 | | | $ | 0.67 | |
| Normalized AFFO | $ | 0.36 | | | $ | 0.34 | | | $ | 0.71 | | | $ | 0.67 | |
| Weighted average number of common shares outstanding, diluted: | | | | | | | |
| | | | | | | |
| Net income, FFO and Normalized FFO | 233,750,823 | | | 232,244,588 | | | 233,583,871 | | | 232,214,443 | |
| AFFO and Normalized AFFO | 234,907,744 | | | 233,586,255 | | | 234,821,672 | | | 233,560,237 | |
(1) Other normalizing items for FFO and AFFO primarily include triple-net operating expenses, net of recoveries.
See reporting definitions. 3
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
EBITDA, Adjusted EBITDA, Adjusted EBITDA, as adjusted and Annualized Adjusted EBITDA, as adjusted
Net Debt and Net Debt to Adjusted EBITDA
(in thousands)
| | | | | |
| Three Months Ended |
| June 30, 2024 |
| |
| |
| Net income | $ | 23,975 | |
| Interest | 29,314 | |
| Income tax expense | 437 | |
| Depreciation and amortization | 41,681 | |
| EBITDA | $ | 95,407 | |
| Income from unconsolidated joint ventures | (80) | |
| |
| Distributions from unconsolidated joint ventures | 1,130 | |
| Stock-based compensation expense | 1,341 | |
| Acquisition and transaction costs | 201 | |
| |
| Recovery of loan losses | (161) | |
| Impairment of real estate | 15,335 | |
| |
| Other expense | 1,190 | |
| |
| Net gain on sales of real estate | (1,776) | |
Adjusted EBITDA (1) | $ | 112,587 | |
Adjustments for current period activity (2) | (1,091) | |
| Adjusted EBITDA, as adjusted | $ | 111,496 | |
| |
| Adjusted EBITDA, as adjusted, annualized | $ | 445,984 | |
| |
| |
| |
| |
| |
| |
| |
| |
| June 30, 2024 |
| Secured debt | $ | 47,134 | |
| Revolving credit facility | 130,367 | |
| Term loans | 539,665 | |
| Senior unsecured notes | 1,750,000 | |
| Consolidated Debt | 2,467,166 | |
| Cash and cash equivalents | (36,398) | |
| Net Debt | $ | 2,430,768 | |
| |
| |
| |
| June 30, 2024 |
| Net Debt | $ | 2,430,768 | |
| Annualized Adjusted EBITDA, as adjusted | $ | 445,984 | |
| Net Debt to Adjusted EBITDA | 5.45x |
(1) Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation and amortization (“EBITDA”) excluding the impact of merger-related costs, stock-based compensation expense under the Company’s long-term equity award program and loan loss reserves.
(2) Adjustments for current period activity give effect to the acquisitions and dispositions completed during the period as though such acquisitions and dispositions were completed as of the beginning of the period and adjust for certain income and expense items that the Company does not believe are indicative of its operating results for the current period.
See reporting definitions. 4
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Consolidated Statements of Income
Supplemental Information
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
| | 2024 | | 2023 | | 2024 | | 2023 |
| Cash rental income | $ | 93,527 | | | $ | 87,381 | | | $ | 182,563 | | | $ | 177,038 | |
| Straight-line rental income | 1,176 | | | 1,503 | | | 2,328 | | | 2,850 | |
| Write-offs of cash and straight-line rental income receivable and lease intangibles | — | | | — | | | (2,954) | | | (518) | |
| Above/below market lease amortization | 1,211 | | | 1,568 | | | 2,422 | | | 3,136 | |
| | | | | | | |
| Operating expense recoveries | 3,182 | | | 3,822 | | | 6,513 | | | 7,638 | |
| Rental and related revenues | $ | 99,096 | | | $ | 94,274 | | | $ | 190,872 | | | $ | 190,144 | |
See reporting definitions. 5
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Senior Housing - Managed Revenues and Cash NOI
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended |
| | June 30, 2023 | | September 30, 2023 | | December 31, 2023 | | March 31, 2024 | | June 30, 2024 |
| Revenues: | | | | | | | | | |
| Resident fees and services | $ | 58,428 | | | $ | 59,748 | | | $ | 61,256 | | | $ | 66,031 | | | $ | 67,939 | |
| (Loss) income from unconsolidated joint ventures: | | | | | | | | | |
| Resident fees and services | 9,760 | | | 9,950 | | | 10,007 | | | 10,362 | | | 10,453 | |
Resident fees and services not included in same store (1) | (4,398) | | | (4,708) | | | (4,990) | | | (9,293) | | | (10,251) | |
| Same store resident fees and services | $ | 63,790 | | | $ | 64,990 | | | $ | 66,273 | | | $ | 67,100 | | | $ | 68,141 | |
| | | | | | | | | |
| | | | | | | | | |
| Net income (loss) | $ | 21,188 | | | $ | (15,101) | | | $ | 17,156 | | | $ | 26,254 | | | $ | 23,975 | |
| Adjustments: | | | | | | | | | |
| Net (income) loss not related to Senior Housing - Managed | (19,638) | | | 18,275 | | | (13,562) | | | (21,673) | | | (17,589) | |
| Depreciation and amortization | 12,279 | | | 11,885 | | | 11,707 | | | 12,084 | | | 11,278 | |
| Other income | — | | | (470) | | | — | | | (898) | | | — | |
| Net (gain) loss on sale of real estate | (18) | | | (9) | | | 5 | | | — | | | — | |
| Loss (income) from unconsolidated joint ventures | 653 | | | 645 | | | 761 | | | 595 | | | (80) | |
| Sabra's share of unconsolidated joint ventures' Net Operating Income | 2,681 | | | 2,612 | | | 2,425 | | | 2,690 | | | 3,236 | |
| Cash Net Operating Income | $ | 17,145 | | | $ | 17,837 | | | $ | 18,492 | | | $ | 19,052 | | | $ | 20,820 | |
| | | | | | | | | |
Cash Net Operating Income not included in same store (1) | 21 | | | 97 | | | (226) | | | (680) | | | (622) | |
| Same store Cash Net Operating Income | $ | 17,166 | | | $ | 17,934 | | | $ | 18,266 | | | $ | 18,372 | | | $ | 20,198 | |
(1) Includes adjustments for changes in the foreign currency exchange rate where applicable by applying the average exchange rate for the current period to prior period results.
See reporting definitions. 6
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Cash NOI by Property Type
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, 2024 |
| Skilled Nursing/ Transitional Care | | Senior Housing | | Behavioral Health | | Specialty Hospitals and Other | | | | | | |
| | Senior Housing - Leased | | Senior Housing - Managed Consolidated | | Senior Housing - Managed Unconsolidated | | Total Senior Housing | | | | Other | | Corporate | | Total |
| Net income (loss) | $ | 44,809 | | | $ | 8,724 | | | $ | 6,306 | | | $ | 80 | | | $ | 15,110 | | | $ | (5,989) | | | $ | 3,330 | | | $ | 9,106 | | | $ | (42,391) | | | $ | 23,975 | |
| Adjustments: | | | | | | | | | | | | | | | | | | | |
| Depreciation and amortization | 21,456 | | | 3,760 | | | 11,278 | | | — | | | 15,038 | | | 3,638 | | | 1,462 | | | — | | | 87 | | | 41,681 | |
| Interest | 202 | | | 216 | | | — | | | — | | | 216 | | | — | | | — | | | — | | | 28,896 | | | 29,314 | |
| General and administrative | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 12,741 | | | 12,741 | |
| Recovery of loan losses and other reserves | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (161) | | | (161) | |
| Impairment of real estate | 2,542 | | | — | | | — | | | — | | | — | | | 12,324 | | | — | | | — | | | 469 | | | 15,335 | |
| | | | | | | | | | | | | | | | | | | |
| Other income | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (78) | | | (78) | |
| Net gain on sales of real estate | (1,776) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (1,776) | |
| Income from unconsolidated joint ventures | — | | | — | | | — | | | (80) | | | (80) | | | — | | | — | | | — | | | — | | | (80) | |
| Income tax expense | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 437 | | | 437 | |
| Sabra’s share of unconsolidated joint ventures’ Net Operating Income | — | | | — | | | — | | | 3,236 | | | 3,236 | | | — | | | — | | | — | | | — | | | 3,236 | |
| Net Operating Income | $ | 67,233 | | | $ | 12,700 | | | $ | 17,584 | | | $ | 3,236 | | | $ | 33,520 | | | $ | 9,973 | | | $ | 4,792 | | | $ | 9,106 | | | $ | — | | | $ | 124,624 | |
| Non-cash revenue and expense adjustments | (1,259) | | | (868) | | | — | | | — | | | (868) | | | (178) | | | (52) | | | 5 | | | — | | | (2,352) | |
| Cash Net Operating Income | $ | 65,974 | | | $ | 11,832 | | | $ | 17,584 | | | $ | 3,236 | | | $ | 32,652 | | | $ | 9,795 | | | $ | 4,740 | | | $ | 9,111 | | | $ | — | | | $ | 122,272 | |
See reporting definitions. 7
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Annualized Cash NOI by Property Type
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Six Months Ended June 30, 2024 |
| Skilled Nursing/ Transitional Care | | Senior Housing | | Behavioral Health | | Specialty Hospitals and Other | | | | | | |
| | Senior Housing - Leased | | Senior Housing - Managed Consolidated | | Senior Housing - Managed Unconsolidated | | Total Senior Housing | | | | Other | | Corporate | | Total |
| Net income (loss) | $ | 82,449 | | | $ | 15,784 | | | $ | 11,482 | | | $ | (515) | | | $ | 26,751 | | | $ | (859) | | | $ | 6,633 | | | $ | 18,046 | | | $ | (82,791) | | | $ | 50,229 | |
| Adjustments: | | | | | | | | | | | | | | | | | | | |
| Depreciation and amortization | 43,053 | | | 7,904 | | | 23,362 | | | — | | | 31,266 | | | 7,195 | | | 2,923 | | | — | | | 158 | | | 84,595 | |
| Interest | 406 | | | 435 | | | — | | | — | | | 435 | | | — | | | — | | | — | | | 56,881 | | | 57,722 | |
| General and administrative | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 24,631 | | | 24,631 | |
| Recovery of loan losses | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (298) | | | (298) | |
| Impairment of real estate | 5,679 | | | — | | | — | | | — | | | — | | | 12,324 | | | — | | | — | | | 469 | | | 18,472 | |
| | | | | | | | | | | | | | | | | | | |
| Other (income) expense | — | | | — | | | (898) | | | — | | | (898) | | | — | | | — | | | — | | | 60 | | | (838) | |
| Net gain on sales of real estate | (1,776) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (1,776) | |
| Loss from unconsolidated joint ventures | — | | | — | | | — | | | 515 | | | 515 | | | — | | | — | | | — | | | — | | | 515 | |
| Income tax expense | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 890 | | | 890 | |
| Sabra’s share of unconsolidated joint ventures’ Net Operating Income | — | | | — | | | — | | | 5,926 | | | 5,926 | | | — | | | — | | | — | | | — | | | 5,926 | |
| Net Operating Income | $ | 129,811 | | | $ | 24,123 | | | $ | 33,946 | | | $ | 5,926 | | | $ | 63,995 | | | $ | 18,660 | | | $ | 9,556 | | | $ | 18,046 | | | $ | — | | | $ | 240,068 | |
| Non-cash revenue and expense adjustments | (2,542) | | | (1,606) | | | — | | | — | | | (1,606) | | | 2,524 | | | (111) | | | 12 | | | — | | | (1,723) | |
| Cash Net Operating Income | $ | 127,269 | | | $ | 22,517 | | | $ | 33,946 | | | $ | 5,926 | | | $ | 62,389 | | | $ | 21,184 | | | $ | 9,445 | | | $ | 18,058 | | | $ | — | | | $ | 238,345 | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Annualizing adjustments (1) | 125,086 | | | 24,099 | | | 36,406 | | | 7,018 | | | 67,523 | | | 22,175 | | | 9,394 | | | 18,094 | | | — | | | 242,272 | |
| Annualized Cash Net Operating Income | $ | 252,355 | | | $ | 46,616 | | | $ | 70,352 | | | $ | 12,944 | | | $ | 129,912 | | | $ | 43,359 | | | $ | 18,839 | | | $ | 36,152 | | | $ | — | | | $ | 480,617 | |
Reallocation adjustments (2) | 1,754 | | | 5,966 | | | — | | | — | | | 5,966 | | | 24,426 | | | — | | | (32,146) | | | — | | | — | |
| Annualized Cash Net Operating Income, as adjusted | $ | 254,109 | | | $ | 52,582 | | | $ | 70,352 | | | $ | 12,944 | | | $ | 135,878 | | | $ | 67,785 | | | $ | 18,839 | | | $ | 4,006 | | | $ | — | | | $ | 480,617 | |
(1) Represents the annual effect of acquisitions, dispositions, lease modifications and scheduled rent increases completed during the period and mathematical adjustments needed to make Cash Net Operating Income for the period representative of Cash Net Operating Income for a full year.
(2) Adjustments to reflect Annualized Cash Net Operating Income from mortgage and construction loans receivable and preferred equity investments in the related asset class of the underlying real estate.
See reporting definitions. 8
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Annualized Cash NOI by Payor Source
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Six Months Ended June 30, 2024 |
| Private Payors | | Non-Private Payors | | Other | | | | Corporate | | Total |
| Net income (loss) | $ | 37,694 | | | $ | 77,280 | | | $ | 18,046 | | | | | $ | (82,791) | | | $ | 50,229 | |
| Adjustments: | | | | | | | | | | | |
| Depreciation and amortization | 42,774 | | | 41,663 | | | — | | | | | 158 | | | 84,595 | |
| Interest | 457 | | | 384 | | | — | | | | | 56,881 | | | 57,722 | |
| General and administrative | — | | | — | | | — | | | | | 24,631 | | | 24,631 | |
| Recovery of loan losses | — | | | — | | | — | | | | | (298) | | | (298) | |
| Impairment of real estate | 12,104 | | | 5,899 | | | — | | | | | 469 | | | 18,472 | |
| | | | | | | | | | | |
| Other (income) expense | (898) | | | — | | | — | | | | | 60 | | | (838) | |
| Net (gain) loss on sales of real estate | (1,888) | | | 112 | | | — | | | | | — | | | (1,776) | |
| Loss from unconsolidated joint ventures | 515 | | | — | | | — | | | | | — | | | 515 | |
| Income tax expense | — | | | — | | | — | | | | | 890 | | | 890 | |
| Sabra’s share of unconsolidated joint ventures’ Net Operating Income | 5,926 | | | — | | | — | | | | | — | | | 5,926 | |
| Net Operating Income | $ | 96,684 | | | $ | 125,338 | | | $ | 18,046 | | | | | $ | — | | | $ | 240,068 | |
| Non-cash revenue and expense adjustments | 152 | | | (1,887) | | | 12 | | | | | — | | | (1,723) | |
| Cash Net Operating Income | $ | 96,836 | | | $ | 123,451 | | | $ | 18,058 | | | | | $ | — | | | $ | 238,345 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Annualizing adjustments (1) | 101,489 | | | 122,689 | | | 18,094 | | | | | — | | | 242,272 | |
| Annualized Cash Net Operating Income | $ | 198,325 | | | $ | 246,140 | | | $ | 36,152 | | | | | $ | — | | | $ | 480,617 | |
(1) Represents the annual effect of acquisitions, dispositions, lease modifications and scheduled rent increases completed during the period and mathematical adjustments needed to make Cash Net Operating Income for the period representative of Cash Net Operating Income for a full year.
See reporting definitions. 9
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Annualized Cash NOI by Relationship
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Six Months Ended June 30, 2024 |
| Signature Healthcare | | Ensign Group | | Avamere Family of Companies | | Signature Behavioral | | Recovery Centers of America | | The McGuire Group | | | | | | | | | | All Other Relationships | | Corporate | | Total |
| Net income (loss) | $ | 11,565 | | | $ | 13,812 | | | $ | 13,646 | | | $ | 11,992 | | | $ | 12,712 | | | $ | 7,190 | | | | | | | | | | | $ | 62,103 | | | $ | (82,791) | | | $ | 50,229 | |
| Adjustments: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Depreciation and amortization | 6,748 | | | 6,491 | | | 5,941 | | | 4,482 | | | 1,022 | | | 3,563 | | | | | | | | | | | 56,190 | | | 158 | | | 84,595 | |
| Interest | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | 841 | | | 56,881 | | | 57,722 | |
| General and administrative | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | — | | | 24,631 | | | 24,631 | |
| Recovery of loan losses | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | — | | | (298) | | | (298) | |
| Impairment of real estate | 2,661 | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | 15,342 | | | 469 | | | 18,472 | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Other (income) expense | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | (898) | | | 60 | | | (838) | |
| Net loss (gain) on sales of real estate | 3 | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | (1,779) | | | — | | | (1,776) | |
| Loss from unconsolidated joint ventures | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | 515 | | | — | | | 515 | |
| Income tax expense | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | — | | | 890 | | | 890 | |
| Sabra’s share of unconsolidated joint ventures’ Net Operating Income | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | 5,926 | | | — | | | 5,926 | |
| Net Operating Income | $ | 20,977 | | | $ | 20,303 | | | $ | 19,587 | | | $ | 16,474 | | | $ | 13,734 | | | $ | 10,753 | | | | | | | | | | | $ | 138,240 | | | $ | — | | | $ | 240,068 | |
| Non-cash revenue and expense adjustments | 11 | | | 26 | | | 51 | | | (291) | | | (73) | | | (1,947) | | | | | | | | | | | 500 | | | — | | | (1,723) | |
| Cash Net Operating Income | $ | 20,988 | | | $ | 20,329 | | | $ | 19,638 | | | $ | 16,183 | | | $ | 13,661 | | | $ | 8,806 | | | | | | | | | | | $ | 138,740 | | | $ | — | | | $ | 238,345 | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
Annualizing adjustments (1) | 21,854 | | | 20,252 | | | 19,229 | | | 16,717 | | | 13,695 | | | 8,861 | | | | | | | | | | | 141,664 | | | — | | | 242,272 | |
| Annualized Cash Net Operating Income | $ | 42,842 | | | $ | 40,581 | | | $ | 38,867 | | | $ | 32,900 | | | $ | 27,356 | | | $ | 17,667 | | | | | | | | | | | $ | 280,404 | | | $ | — | | | $ | 480,617 | |
(1) Represents the annual effect of acquisitions, dispositions, lease modifications and scheduled rent increases completed during the period and mathematical adjustments needed to make Cash Net Operating Income for the period representative of Cash Net Operating Income for a full year.
See reporting definitions. 10
SABRA HEALTH CARE REIT, INC.
REPORTING DEFINITIONS
Adjusted EBITDA. Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation and amortization (“EBITDA”) excluding the impact of merger-related costs, stock-based compensation expense under the Company's long-term equity award program, and loan loss reserves. Adjusted EBITDA is an important non-GAAP supplemental measure of operating performance.
Annualized Cash Net Operating Income (“Annualized Cash NOI”). The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers Annualized Cash NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines Annualized Cash NOI as Annualized Revenues less operating expenses and non-cash revenues and expenses. Annualized Cash NOI excludes all other financial statement amounts included in net income.
Annualized Revenues. The annual contractual rental revenues under leases and interest and other income generated by the Company’s loans receivable and other investments based on amounts invested and applicable terms as of the end of the period presented. Annualized Revenues do not include tenant recoveries or additional rents and are adjusted to reflect actual payments received related to the twelve months ended at the end of the respective period for leases no longer accounted for on an accrual basis.
Behavioral Health. Includes behavioral hospitals that provide inpatient and outpatient care for patients with mental health conditions, chemical dependence or substance addictions and addiction treatment centers that provide treatment services for chemical dependence and substance addictions, which may include inpatient care, outpatient care, medical detoxification, therapy and counseling.
Cash Net Operating Income (“Cash NOI”). The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers Cash NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines Cash NOI as total revenues less operating expenses and non-cash revenues and expenses. Cash NOI excludes all other financial statement amounts included in net income.
Consolidated Debt. The principal balances of the Company’s revolving credit facility, term loans, senior unsecured notes, and secured indebtedness as reported in the Company’s consolidated financial statements.
Funds From Operations (“FFO”) and Adjusted Funds from Operations (“AFFO”). The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company also believes that funds from operations, or FFO, as defined in accordance with the definition used by the National Association of Real Estate Investment Trusts (“Nareit”), and adjusted funds from operations, or AFFO (and related per share amounts) are important non-GAAP supplemental measures of the Company’s operating performance. Because the historical cost accounting convention used for real estate assets requires straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. Thus, Nareit created FFO as a supplemental measure of operating performance for real estate investment trusts that excludes historical cost depreciation and amortization, among other items, from net income, as defined by GAAP. FFO is defined as net income, computed in accordance with GAAP, excluding gains or losses from real estate dispositions and the Company’s share of gains or losses from real estate dispositions related to its unconsolidated joint ventures, plus real estate depreciation and amortization, net of amounts related to noncontrolling interests, plus the Company’s share of depreciation and amortization related to its unconsolidated joint ventures, and real estate impairment charges of both consolidated and unconsolidated entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity. AFFO is defined as FFO excluding stock-based compensation expense, non-cash rental and related revenues, non-cash interest income, non-cash interest expense, non-cash portion of loss on extinguishment of debt, provision for (recovery of) loan losses and other reserves, non-cash lease termination income and deferred income taxes, as well as other non-cash revenue and expense items (including noncapitalizable acquisition costs, transaction costs related to operator transitions and organizational or other restructuring activities, ineffectiveness gain/loss on derivative instruments, and non-cash revenue and expense amounts related to noncontrolling interests) and the Company’s share of non-cash adjustments related to its unconsolidated joint ventures. The Company believes that the use of FFO and AFFO (and the related per share amounts), combined with the required GAAP presentations, improves the understanding of the Company’s operating results among investors and makes comparisons of operating results among real estate investment trusts more meaningful. The Company considers FFO and AFFO to be useful measures for reviewing comparative operating and financial performance because, by excluding the applicable items listed above, FFO and AFFO can help investors compare the operating performance of the Company between periods or as compared to other companies. While FFO and AFFO are relevant and widely used measures of operating performance of real estate investment trusts, they do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. FFO and AFFO also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor do they purport to be indicative of cash available to fund the Company’s future cash requirements. Further, the Company’s computation of FFO and AFFO may not be comparable to FFO and AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current Nareit definition or that interpret the current Nareit definition or define AFFO differently than the Company does.
Net Debt. The principal balances of the Company’s revolving credit facility, term loans, senior unsecured notes, and secured indebtedness as reported in the Company’s consolidated financial statements, net of cash and cash equivalents as reported in the Company’s consolidated financial statements.
Net Debt to Adjusted EBITDA. Net Debt to Adjusted EBITDA is calculated as Net Debt divided by Annualized Adjusted EBITDA, which is Adjusted EBITDA, as adjusted for annualizing adjustments that give effect to the acquisitions and dispositions completed during the respective period as though such acquisitions and dispositions were completed as of the beginning of the period presented.
Net Operating Income (“NOI”). The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines NOI as total revenues less operating expenses. NOI excludes all other financial statement amounts included in net income.
See reporting definitions. 11
SABRA HEALTH CARE REIT, INC.
REPORTING DEFINITIONS
Normalized FFO and Normalized AFFO. Normalized FFO and Normalized AFFO represent FFO and AFFO, respectively, adjusted for certain income and expense items that the Company does not believe are indicative of its ongoing operating results. The Company considers Normalized FFO and Normalized AFFO to be useful measures to evaluate the Company’s operating results excluding these income and expense items to help investors compare the operating performance of the Company between periods or as compared to other companies. Normalized FFO and Normalized AFFO do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. Normalized FFO and Normalized AFFO also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor do they purport to be indicative of cash available to fund the Company’s future cash requirements. Further, the Company’s computation of Normalized FFO and Normalized AFFO may not be comparable to Normalized FFO and Normalized AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current Nareit definition or that interpret the current Nareit definition or define FFO and AFFO or Normalized FFO and Normalized AFFO differently than the Company does.
Senior Housing. Senior Housing communities include independent living, assisted living, continuing care retirement and memory care communities.
Senior Housing - Managed. Senior Housing communities operated by third-party property managers pursuant to property management agreements.
Skilled Nursing/Transitional Care. Skilled Nursing/Transitional Care facilities include skilled nursing, transitional care, multi-license designation and mental health facilities.
Specialty Hospitals and Other. Includes acute care, long-term acute care and rehabilitation hospitals, facilities that provide residential services, which may include assistance with activities of daily living, and other facilities not classified as Skilled Nursing/Transitional Care, Senior Housing or Behavioral Health.
See reporting definitions. 12 